Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.66−0.03 (-1.78%)
Close on Nov 12, 2026Market cap $590.23MP/E –Yield –
Evotec enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evotec's enterprise value was $224.98M on Nov 11, 2026, against $858.55M a year earlier. Over the last 5 years it ranged from $167.79M to $7.70B, with a median of $1.29B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $224.98M | -70.6% |
| 2025 | Dec 31, 2025 | $765.97M | -29.1% |
| 2024 | Dec 31, 2024 | $1.08B | -73.4% |
| 2023 | Dec 29, 2023 | $4.06B | +62.5% |
| 2022 | Dec 30, 2022 | $2.50B | -67.6% |
| 2021 | Dec 31, 2021 | $7.70B | +49.4% |
| 2020 | Dec 31, 2020 | $5.16B | – |
See a number that looks wrong?